← Russell 3000 cross-section

DLB Dolby Laboratories, Inc.

Trailing twelve months to 2026-06-26 · as filed 2026-07-30, not restated
Financials

Scale

Market cap
$6.2bn
Revenue TTM
$1.4bn
Net income TTM
$226m
Free cash flow
$393m
Composite score
31.1
Sector rank
#948

Valuation

P / E
27.4
EV / EBITDA
EV / sales
4.1
FCF yield
6.34%
Earnings yield vs 10-yr
-1.08pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
16.7%
EBITDA margin
ROE
8.8%
ROIC
12.5%
Revenue growth
0.6%

Insider activity, last 90 days

Net open-market
$-1.66m
Buyers
0
Sellers
3

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

We generated over 90% of our revenue in the third quarters of fiscal 2026 and fiscal 2025, and the fiscal year-to-date periods ended June 26, 2026 and June 27, 2025 from agreements to license branded technology and patents that enable approximately 1,000 electroni c device manufacturers to enable and enhance the audio and visual capabilities of their products by incorporating our technology. GAAP, we estimate the number of units each customer sells every quarter and record it as revenue, and then true up that estimate when we get the actual unit sales data, typically one quarter in arrears. …Dolby Laboratories, Inc., 10-Q, period ended 2026-06-26, filed 2026-07-30

Read the full passage →